Patient survival is a parameter that is difficult to accurately assess, especially when using small sample groups, as it is reliant on a myriad of factors that include tumor type, patient’s characteristics, such as age or family history, the degree of systemic inflammation, and nutritional indicators, such as BMI or tumor markers, like CEA [134]. The gene discussed is CEACAM5; the disease is neoplasm.